Genomic architecture of sickle cell disease in West African children

Frontiers in Genetics

Volumn 5, Issue FEB, 2014, Pages

  Quinlan, Jacklyn ^a   Idaghdour, Youssef ^a,b   Goulet, Jean Philippe ^a   Gbeha, Elias ^a   de Malliard, Thibault ^a   Bruat, Vanessa ^a   Grenier, Jean Christophe ^a   Gomez, Selma ^c   Sanni, Ambaliou ^c   Rahimy, Mohamed C ^c   Awadalla, Philip ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NEW YORK UNIVERSITY ABU DHABI   (United Arab Emirates)

^c UNIVERSITY OF ABOMEY CALAVI   (Benin)

Author keywords

ESNP mapping; Gene by environment interactions; Genomics; Sickle cell disease; Transcriptome

Indexed keywords

HEMOGLOBIN BETA CHAIN;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INTERACTION; GENE MAPPING; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84897716074     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00026     Document Type: Article

References (42)

1. Adams, G. T., Snieder, H., Mckie, V. C., Clair, B., Brambilla, D., Adams, R. J., et al. (2003). Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen. BMC Med. Genet. 4:6. doi: 10.1186/1471-2350-4-6.
2. Akinsheye, I., Alsultan, A., Solovieff, N., Ngo, D., Baldwin, C. T., Sebastiani, P., et al. (2011). Fetal hemoglobin in sickle cell anemia. Blood 118, 19-27. doi: 10.1182/blood-2011-03-325258.
3. Barreiro, L. B., Tailleux, L., Pai, A. A., Gicquel, B., Marioni, J. C., and Gilad, Y. (2012). Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U. S. A. 109, 1204-1209. doi: 10.1073/pnas.1115761109.
4. Berry, M. P., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A., Oni, T., et al. (2010). An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973-977. doi: 10.1038/nature09247.
5. Cookson, W., Liang, L., Abecasis, G., Moffatt, M., and Lathrop, M. (2009). Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 10, 184 -194. doi: 10.1038/nrg2537.
6. Driss, A., Asare, K. O., Hibbert, J. M., Gee, B. E., Adamkiewicz, T. V., and Stiles, J. K. (2009). Sickle cell disease in the post genomic era: a monogenic disease with a polygenic phenotype. Genomics Insights 2009, 23-48.
7. Edelstein, L. C., Luna, E. J., Gibson, I. B., Bray, M., Jin, Y., et al. (2012). Human genome-wide aassociation and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stress. Circulation 125, 2762-2771. doi: 10.1161/CIRCULATIONAHA.112.091462.
8. Emilsson, V., Thorleifsson, G., Zhang, B., Leonardson, A. S., Zink, F., Zhu, J., et al. (2008). Genetics of gene expression and its effect on disease. Nature 452, 423-428. doi: 10.1038/nature06758.
9. Hannemann, A., Weiss, E., Rees, D. C., Dalibalta, S., Ellory, J. C., and Gibson, J. S. (2011). The properties of red blood cells from patients heterozygous for HbS and HbC (HbSC Genotype). Anemia 2011, 248527. doi: 10.1155/2011/248527.
10. Horcher, M., Souabni, A., and Busslinger, M. (2001). Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 14, 779-790. doi: 10.1016/S1074-7613(01)00153-4.
11. Idaghdour, Y., and Awadalla, P. (2012). Exploiting gene expression variation to capture gene-environment interactions for disease. Front. Genet. 3:228. doi: 10.3389/fgene.2012.00228.
12. Idaghdour, Y., Quinlan, J., Goulet, J. P., Berghout, J., Gbeha, E., Bruat, V., et al. (2012). Evidence for additive and interaction effects of host genotype and infection in malaria. Proc. Natl. Acad. Sci. U.S.A. 109, 16786-16793. doi: 10.1073/pnas.1204945109.
13. Jison, M. L., Munson, P. J., Barb, J. J., Suffredini, A. F., Talwar, S., Logun, C., et al. (2004). Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 104, 270-280. doi: 10.1182/blood-2003-08-2760.
14. Kato, N., Takeuchi, F., Tabara, Y., Kelly, T. N., Go, M. J., Sim, X., et al. (2011). Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat. Genet. 43, 531-538. doi: 10.1038/ng.834.
15. Kuhlman, P. A., and Fowler, V. M. (1997). Purification and characterization of an alpha 1 beta 2 isoform of CapZ from human erythrocytes: cytosolic location and inability to bind to Mg2+ ghosts suggest that erythrocyte actin filaments are capped by adducin. Biochemistry 36, 13461-13472. doi: 10.1021/bi970601b.
16. Lettre, G., Sankaran, V. G., Bezerra, M. A., Araujo, A. S., Uda, M., Sanna, S., et al. (2008). DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc. Natl. Acad. Sci. U. S. A. 105, 11869-11874. doi: 10.1073/pnas.0804799105.
17. Liu, H. P., Yu, M. C., Jiang, M. H., Chen, J. X., Yan, D. P., Liu, F., et al. (2011). Association of supervillin with KIR2DL1 regulates the inhibitory signaling of natural killer cells. Cell. Signal 23, 487-496. doi: 10.1016/j.cellsig.2010.11.001.
18. Liu, Y., Niu, W., Wu, Z., Su, X., Chen, Q., Lu, L., et al. (2012). Variants in exon 11 of MEF2A gene and coronary artery disease: evidence from a case-control study, systematic review, and meta-analysis. PLoS ONE 7:e31406. doi: 10.1371/journal.pone.0031406.
19. Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., et al. (2007). A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat. Genet. 39, 1197-1199. doi: 10.1038/ng2108.
20. Musa, B. O., Onyemelukwe, G. C., Hambolu, J. O., Mamman, A. I., and Isa, A. H. (2010). Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis. Clin. Vaccine Immunol. 17, 602-608. doi: 10.1128/CVI.00145-09.
21. Papait, R., Cattaneo, P., Kunderfranco, P., Greco, C., Carullo, P., Guffanti, A., et al. (2013). Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 110, 20164-20169. doi: 10.1073/pnas.1315155110.
22. Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., and Reich, D. (2006). Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909. doi: 10.1038/ng1847.
23. Pritchard, J. K., Stephens, M., and Donnelly, P. (2000). Inference of population structure using multilocus genotype data. Genetics 155, 945-959.
24. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., et al. (2007). PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575. doi: 10.1086/519795.
25. Raghavachari, N., Xu, X., Harris, A., Villagra, J., Logun, C., Barb, J., et al. (2007). Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation 115, 1551-1562. doi: 10.1161/CIRCULATIONAHA.106.658641.
26. Rahimy, M. C., Gangbo, A., Ahouignan, G., Adjou, R., Deguenon, C., Goussanou, S., et al. (2003). Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting. Blood 102, 834-838. doi: 10.1182/blood-2002-05-1453.
27. Romanoski, C. E., Lee, S., Kim, M. J., Ingram-Drake, L., Plaisier, C. L., Yordanova, R., et al. (2010). Systems genetics analysis of gene-by-environment interactions in human cells. Am. J. Hum. Genet. 86, 399-410. doi: 10.1016/j.ajhg.2010.02.002.
28. Sankaran, V. G., Lettre, G., Orkin, S. H., and Hirschhorn, J. N. (2010). Modifier genes in Mendelian disorders: the example of hemoglobin disorders. Ann. N.Y. Acad. Sci. 1214, 47-56. doi: 10.1111/j.1749-6632.2010.05821.x.
29. Sebastiani, P., Nolan, V. G., Baldwin, C. T., Abad-Grau, M. M., Wang, L., Adewoye, A. H., et al. (2007). A network model to predict the risk of death in sickle cell disease. Blood 110, 2727-2735. doi: 10.1182/blood-2007-04-084921.
30. Sebastiani, P., Solovieff, N., Hartley, S. W., Milton, J. N., Riva, A., Dworkis, D. A., et al. (2010). Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study. Am. J. Hematol. 85, 29-35. doi: 10.1002/ajh.21572.
31. Smirnov, D. A., Morley, M., Shin, E., Spielman, R. S., and Cheung, V. G. (2009). Genetic analysis of radiation-induced changes in human gene expression. Nature 459, 587-591. doi: 10.1038/nature07940.
32. Solovieff, N., Milton, J. N., Hartley, S. W., Sherva, R., Sebastiani, P., Dworkis, D. A., et al. (2010). Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster. Blood 115, 1815-1822. doi: 10.1182/blood-2009-08-239517.
33. Steinberg, M. H., and Sebastiani, P. (2012). Genetic modifiers of sickle cell disease. Am. J. Hematol. 87, 795-803. doi: 10.1002/ajh.23232.
34. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550. doi: 10.1073/pnas.0506580102.
35. Thein, S. L. (2011). Genetic modifiers of sickle cell disease. Hemoglobin 35, 589-606. doi: 10.3109/03630269.2011.615876.
36. Venkataraman, M., and Westerman, M. P. (1985). B-cell changes occur in patients with sickle cellanemia. Am. J. Clin. Pathol. 84, 153-158.
37. Villagra, J., Shiva, S., Hunter, L. A., Machado, R. F., Gladwin, M. T., and Kato, G. J. (2007). Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 110, 2166-2172. doi: 10.1182/blood-2006-12-061697.
38. Weatherall, D. J. (2001). Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat. Rev. Genet. 2, 245-255. doi: 10.1038/35066048.
39. Westra, H. J., Peters, M. J., Esko, T., Yaghootkar, H., Schurmann, C., Kettunen, J., et al. (2013). Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238-1243. doi: 10.1038/ng.2756.
40. World Health Organization, T. W. H. A. (2006). "Sickle cell anaemia", in Report by the Secretariat in Provisional Agenda Item 11.4. A59/9. Geneva: World Health Organization.
41. Yu, J., Pressoir, G., Briggs, W. H., Vroh Bi, I., Yamasaki, M., Doebley, J. F., et al. (2006). A unified mixed-model method for association mapping that accounts for multiple levels of relatedness. Nat. Genet. 38, 203-208. doi: 10.1038/ng1702.
42. Zhao, W., Zhao, S. P., and Peng, D. Q. (2012). The effects of myocyte enhancer factor 2A gene on the proliferation, migration and phenotype of vascular smooth muscle cells. Cell Biochem. Funct. 30, 108-113. doi: 10.1002/cbf.1823.